glp-1 conversion Market Overview: Agonists and the Obesity Market | Blog glp-1 conversion chart Comparative Effectiveness

M., & Moore, M

Combining GLP-1 receptor agonists with DPP-4 inhibitors is generally not recommended due to limited additive benefit

A GLP-1 weight loss program review should answer more than one question: Will I lose weight? The better question is whether the program gives you safe prescribing, realistic expectations, consistent follow-up, and a plan you can continue after the first few months

The first presentation, "Psychedelics: Promise, Peril, and Health Equity in African Americans," examines one of the most important questions facing psychiatry today: As new psychiatric treatments emerge, will all communities have equitable access to them

doi:10.2337/diab.26.5.480 314